Pharma- biotech- Patent Commercialisation

September 28, 2021, 6:05 pm

Exploring the intersection of microorganisms and patent laws

Microorganisms play a crucial role in leading several natural as well as industrial processes. Moreover, they form the backbone of numerous industries such as the pharmaceutical industry, baking goods industry, and brewing industry. In fact, the usage of microorganisms... Read More

August 6, 2021, 4:41 pm

Cell Source Inc. announced that they have received two patents for their Veto Cell Technology, which has been issued by the United States Patent and Trademark Office (USPTO). The first patent is the “Veto Cells Generated from Memory T Cells” and the second patent is the “Method of Transplantation and Disease Treatment.”... Read More

June 24, 2021, 5:14 pm

A patent infringement suit has been filed by Panacea Biotech Limited before the Delhi High Court for restraining Sanofi Healthcare India Pvt. Ltd. from marketing Hexavalent vaccine which will infringe Panacea’s patent for its fully liquid Whole-Cell Pertussis based fully liquid Hexavalent Vaccine,... Read More

June 21, 2021, 5:30 pm

The United States Patent Office issues a patent for a wearable artificial kidney to Nephrologists Victor Gura, MD, Chairman and Chief Scientific Officer of Wearable Artificial Organs Inc. The clinical trial is expected to start this year to test the third-generation device. The Patentee Gura is an... Read More

May 26, 2021, 9:01 am

For a business, the development of IP is an important part but more important is the efficient management of IP in the business. The business considers the IP as a strong asset for it and hence it is imperative to have a strong strategic portion for the IP to maximize the profit-making part. In the field of Healthcare and its greater reliance on the aspects of AI and... Read More

March 26, 2021, 9:05 am

The decision of the Controller of Patent to revoke Novartis’ patent on the anti-cancer drug Ceritinib, was quashed by the Intellectual Property Appellate Board (IPAB). This decision examines several issues concerning the novelty and obviousness, the extent of coverage and disclosure, and timelines for filing the evidence. The IPAB while quashing the decision held that... Read More

January 30, 2021, 10:20 am

The latest case of Horizon Pharma vs. Dr. Reddy touches upon an important aspect of drafting the specification and indefiniteness in the US Patent Law. 35 U.S.C. § 112(b), which says that the specification shall conclude with one or more claims particularly pointing out and distinctly claiming the... Read More

January 12, 2021, 10:13 am

The denial of the market entry often concerns the access to essential and cheaper medicines and in a larger picture, the public health issue. The availability of generic drugs being subjected to any such preceding condition irrespective of any infringement does affect the larger issues of access to medicine. Patent linkage is perhaps one of the most debatable aspects of... Read More

January 4, 2021, 6:12 pm

The exclusive rights that the Intellectual Property Rights provides to an inventor and a creator in consideration for the efforts being taken by them so that they could reap commercial benefits out of their work, substantiates the importance of IP. Giving due importance to the intellectual labor associated with the innovation is what makes the process of... Read More

March 31, 2020, 10:14 am

We all know about the Covid-19 pandemic that has hit the world like lightning unless you have been living under a giant rock. The scare of it seems to be increasing with every passing day and rightly so because even though doctors and researchers are working day and night, there is no sign of vaccine as of now. There are 2, 77,004 cases as of now out of which 91,986 have... Read More

Pages